Our immuno precipitation experimentspresent evidence that, treatment of glioma cells with hUCBSC leads to thearrest of cell-cycle progression through inactivation of both cyclin D1/Cdk4 and cyclin D1/Cdk 6 complexes. Here, CDK4 is linked to glioma.